Arsenic trioxide injection
Products billed under this code include Arsenic Trioxide, Trisenox.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Arsenic Trioxide, Trisenox.
Payment limit per 1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Arsenic Trioxide | Sandoz Inc. | 00781-3498-94 | 12 | $46.044 |
| Arsenic Trioxide | Sandoz Inc. | 00781-3498-95 | 120 | $460.44 |
| Arsenic Trioxide | Nexus Pharmaceuticals, LLC | 14789-0600-10 | 100 | $383.70 |
| Arsenic Trioxide | Heritage Pharmaceuticals Inc. | 23155-0869-41 | 100 | $383.70 |
| Arsenic Trioxide | Heritage Pharmaceuticals Inc. | 23155-0870-41 | 120 | $460.44 |
| Arsenic Trioxide | Sagent Pharmaceuticals | 25021-0226-10 | 100 | $383.70 |
| Arsenic Trioxide | Sagent Pharmaceuticals | 25021-0227-06 | 120 | $460.44 |
| Arsenic Trioxide | Ingenus Pharmaceuticals LLC | 50742-0438-10 | 10 | $38.37 |
| Arsenic Trioxide | FreseniUS Kabi USA, LLC | 63323-0637-10 | 100 | $383.70 |
| Arsenic Trioxide | Zydus Pharmaceuticals (USA) Inc. | 68382-0997-10 | 100 | $383.70 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Arsenic Trioxide | Nordic Pharma, Inc | 69918-0720-02 | 20 | $76.74 |
| Arsenic Trioxide | Nordic Pharma, Inc | 69918-0720-10 | 100 | $383.70 |
| Arsenic Trioxide | Amneal Pharmaceuticals, LLC | 70121-1483-07 | 100 | $383.70 |
| Arsenic Trioxide | Amneal Pharmaceuticals, LLC | 70121-1658-01 | 120 | $460.44 |
| Arsenic Trioxide | Zydus Pharmaceuticals (USA) Inc. | 70710-1610-06 | 120 | $460.44 |
| Arsenic Trioxide | Zydus Pharmaceuticals (USA) Inc. | 70710-1895-06 | 100 | $383.70 |
| Arsenic Trioxide | Zydus Pharmaceuticals (USA) Inc. | 70710-1896-06 | 120 | $460.44 |
| Arsenic Trioxide | Athenex Pharmaceutical Division, LLC | 70860-0217-10 | 10 | $38.37 |
| Arsenic Trioxide | Novadoz Pharmaceuticals LLC | 72205-0171-07 | 100 | $383.70 |
| Arsenic Trioxide | Novadoz Pharmaceuticals LLC | 72205-0172-07 | 120 | $460.44 |
| Arsenic Trioxide | Northstar RxLLC | 72603-0339-10 | 100 | $383.70 |
| Trisenox | Cephalon, LLC | 63459-0601-06 | 120 | $460.44 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $3.837 | −$1.232 | 1 MG | Arsenic trioxide injection | v1, posted September 17, 2026 |
| 3Q26 | $5.069 | −$1.376 | 1 MG | Arsenic trioxide injection | v1, posted September 15, 2026 |
| 2Q26 | $6.445 | −$0.943 | 1 MG | Arsenic trioxide injection | v1, posted September 15, 2026 |
| 1Q26 | $7.388 | −$0.765 | 1 MG | Arsenic trioxide injection | v1, posted September 15, 2026 |
| 4Q25 | $8.153 | +$2.296 | 1 MG | Arsenic trioxide injection | v1, posted September 8, 2026 |
| 3Q25 | $5.857 | +$1.067 | 1 MG | Arsenic trioxide injection | v1, posted March 10, 2026 |
| 2Q25 | $4.79 | +$0.109 | 1 MG | Arsenic trioxide injection | v1, posted March 10, 2026 |
| 1Q25 | $4.681 | −$2.518 | 1 MG | Arsenic trioxide injection | v1, posted December 19, 2025 |
| 4Q24 | $7.199 | −$3.488 | 1 MG | Arsenic trioxide injection | v1, posted June 11, 2025 |
| 3Q24 | $10.687 | −$1.212 | 1 MG | Arsenic trioxide injection | v1, posted June 11, 2025 |
| 2Q24 | $11.899 | −$3.884 | 1 MG | Arsenic trioxide injection | v1, posted March 11, 2025 |
| 1Q24 | $15.783 | −$2.716 | 1 MG | Arsenic trioxide injection | v1, posted December 19, 2024 |
| 4Q23 | $18.499 | +$5.533 | 1 MG | Arsenic trioxide injection | v1, posted October 10, 2024 |
| 3Q23 | $12.966 | −$0.732 | 1 MG | Arsenic trioxide injection | v1, posted June 5, 2024 |
| 2Q23 | $13.698 | −$2.209 | 1 MG | Arsenic trioxide injection | v1, posted February 23, 2024 |
| 1Q23 | $15.907 | +$0.536 | 1 MG | Arsenic trioxide injection | v1, posted December 6, 2023 |
| 4Q22 | $15.371 | +$3.037 | 1 MG | Arsenic trioxide injection | v1, posted June 22, 2023 |
| 3Q22 | $12.334 | −$1.878 | 1 MG | Arsenic trioxide injection | v1, posted June 9, 2023 |
| 2Q22 | $14.212 | +$1.401 | 1 MG | Arsenic trioxide injection | v1, posted December 14, 2022 |
| 1Q22 | $12.811 | −$0.303 | 1 MG | Arsenic trioxide injection | v1, posted June 8, 2022 |
| 4Q21 | $13.114 | −$5.317 | 1 MG | Arsenic trioxide injection | v1, posted June 2, 2022 |
| 3Q21 | $18.431 | −$5.267 | 1 MG | Arsenic trioxide injection | v1, posted June 2, 2022 |
| 2Q21 | $23.698 | +$5.875 | 1 MG | Arsenic trioxide injection | v1, posted March 1, 2022 |
| 1Q21 | $17.823 | – | 1 MG | Arsenic trioxide injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.